Navigation Links
Arbios Announces Management Changes
Date:9/19/2007

WALTHAM, Mass., Sept. 19 /PRNewswire-FirstCall/ -- Arbios Systems, Inc. (OTC: ABOS) today announced Walter C. Ogier has resigned as President and CEO and as a member of the Company's Board of Directors. The Arbios Board of Directors has appointed Shawn P. Cain, previously Vice President of Operations, to serve as interim President and CEO. The Company plans to initiate a search for a new President and CEO.

Arbios also announced that its Board of Directors has elected Amy Factor as Vice Chairman. Ms. Factor is a former CEO of Arbios and Director of the Company. In addition, the Company announced the formation of an Office of the Chairman which is composed of Company Directors John M. Vierling, M.D., Dennis Kogod and Amy Factor. The Office of the Chairman will provide executive Board assistance in the operations and strategic management of the Company.

"The Board of Directors thanks Walter for his contributions to our company and we wish him well in his future endeavors," commented John M. Vierling, M.D., Chairman of the Board of Director of Arbios. "With promising data supporting the proof-of-concept of our SEPET(TM) Liver Assist Device, Arbios is now focused on forging a pathway to regulatory approval and commercialization of our first product."

About Arbios Systems

Arbios Systems, Inc. is developing proprietary medical devices and cell- based therapies to enhance the survival of millions of patients each year who experience, or are at risk for, life-threatening episodes of liver failure. The Arbios product candidate portfolio includes the SEPET(TM) Liver Assist Device, a novel blood purification therapy that provides enhanced "liver dialysis," and the HepatAssist(TM) Cell-Based Liver Support System, a bioartificial liver that combines blood detoxification with liver cell therapy to replace whole liver function in patients with the most severe forms of liver failure. For more information on the Company, please visit

SOURCE Arbios Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...Animal studies suggest that adding flaxseed oil to... post-menopausal women and women with diabetes, ac...ational Journal of Food Safety, Nutrition and Publ...tional Research Center, in Cairo, Egypt, have stud...uated how flaxseed oil in the diet might delay the...
(Date:11/23/2009)...Since 1996, crop plants genetically modified to pr... insects, yet safe for people, have been planted o...pularity of these Bt crops, named after the bacter...lity to kill some major pests, allowing farmers to...ducing insecticide sprays. , However, since inse...
(Date:11/23/2009)...ding drug to chemo regimen may improve patient out.... 23 (HealthDay News) -- A new combination drug th...nced biliary-tract cancers, researchers say. , ...Cancer Center in Boston found that survival and tu...(Avastin), an angiogenesis inhibitor that has help...
(Date:11/23/2009)...V patients who have it take longer to get sick, st... News) -- Scientists report that a genetic variati... progression in HIV-infected patients. , In f... longer to develop AIDS and die of complications o...that vary across individuals that make a person mo...
(Date:11/23/2009)...,, ,, NASHVILLE,Tenn.,Nov.23/PRNewswire...gedcaremarketintelligence,reportsthatself-insuredm...thCareGrouphaveexperiencedanaggregatehealthcare-co...tthreeyearsofparticipationinahigh-performanceprovi... thecoalitionfoundtheseself-insuredmembercompanies...
Breaking Medicine News(10 mins):Health News:Flaxseed oil and osteoporosis 2Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2Health News:Genetic Variant Slows AIDS Progression 2Health News:Milwaukee Employers See Cost Savings with High-Performance Provider Network 2
...is about the same as using drugs for treatment, st...y News) -- Giving blood transfusions to treat anem...ially lethal blood clots, say University of Roches...lyzed data on more than 70,500 cancer patients who...
...28 HMS Holdings Corp.,(Nasdaq: HMSY ) today ann...er,Jaffray Healthcare Conference, which will be he.... , Walter Hosp, CFO, will present on Tuesday, D...rity services for government healthcare programs.,...
...ght boost understanding of the disease generally, ...hDay News) -- The adult children of people with th... being sought for a new study to better understand...nset form of Alzheimer,s are needed for the six-ye...
...cals make some playthings unfit for kids, report c... -- Plastic fish squirt guns and plastic ponies co...ates. , Toy cars and toy earrings laced with lead....day season, but that they shouldn,t find their way...
..., Nov. 28 VIDA Diagnostics Inc. announced,today t... (PW2) has obtained,FDA 510(k) clearance for sale....ng image analysis software from,VIDA and comprises...ystem measurement functions. , "We are privi...
... Serving as a model for public health a...organization has launched the D*action Community P...nd individuals committed to solving the worldwide ... p.m. , San Diego, CA (PR...
Other Medicine News:Health News:Transfusing Anemic Cancer Patients Boosts Clot Risk 2Health News:Study Recruiting From Alzheimer's-Prone Families 2Health News:Beware of Toxic Toys This Holiday Season 2Health News:Beware of Toxic Toys This Holiday Season 3Health News:VIDA Diagnostics Gains FDA Approval for Comprehensive Lung Analysis Software 2Health News:Grassrootshealth Launches D*action Community Project to Solve Vitamin D Deficiency Crisis 2Health News:Grassrootshealth Launches D*action Community Project to Solve Vitamin D Deficiency Crisis 3
(Date:11/23/2009)...BridgePointMedicalannouncedtodaythatitreceivedEuro...ripheralChronicTotalOcclusion(CTO)CrossingSystemco...Stingray®CTORe-EntrySystem.TheBridgePointSyst...dtonavigatehighlydiseasedarteriesinpreparationforb..., TheNationalHeart,LungandBloodInstitute(NHLBI)est...
(Date:11/23/2009)...wire-FirstCall/-- LexiconPharmaceuticals,Inc. (Nas...hase2clinicalstudywith LX1031 inpatientswithnon-co...edatGASTRO2009inLondonthisweek.Resultsfromthestudy...illbepresentedbyDr. PhilipM.Brown ,Lexicon,ssenior...09at2:30pmlocaltimeatthesessionentitled,"Therapeut...
(Date:11/23/2009)...e-FirstCall/--WoundManagementTechnologies,Inc.,(OT...altymedicalproducts,announcedthatithasfileditQ3200...ementbusinessupdatetoillustratethedevelopmentsduri...33.5%to$102,926vs.Q32008salesof$77,084. , Sha....Q32008shareholderequityof$(321,257) , Totala...
Breaking Medicine Technology:BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Obama Signs Tough New Anti Smoking Law 49671 1Obama Signs Tough New Anti Smoking Law 49671 2Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 1Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 2Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 3Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 4Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 5Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 6Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 7Vermont Receives National Award for Physician e Prescribing Thanks to Efforts by Local Healthcare Firm 49668 1Vermont Receives National Award for Physician e Prescribing Thanks to Efforts by Local Healthcare Firm 49668 2
... Va., Jan. 4 Innocoll, Inc., a privately-held,spe...first of a series of,planned phase 2 clinical tria...ll Technologies Ltd, to investigate CollaRx(R) BUP...st-operative pain, has commenced dosing., Innocol...e and fully,bioresorbable matrix of purified fibri...
...Calif., Jan. 3 Watson,Pharmaceuticals, Inc. (NYSE...ny, announced today it has launched Clarithromycin...gth. Watson,s Clarithromycin,Extended-Release prod...),XL, which is indicated to treat or prevent infec...caused by susceptible bacteria. For the 12-months,...
Other Medicine Technology:Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 4Watson Launches Generic Biaxin(R) XL 2
8-multi channel rack
...c PTFE membranes,Millex filter units with hydropho...ing filtration of gases, for venting of sterile co...c solutions. Ready-to-use sterile 25 mm Millex fil...ections; other filter units can be autoclaved prio...
...icity personal water system is an economical alter... water. In addition to the ongoing expense to purc...y applications may be at risk - as contamination c...lity to degrade over time. Simplicity ultrapure wa...
...r, , Ultrapure Water Quality On Demand, The Super-...lish" to water which has been pretreated by revers...lus systems consistently produce ultrapure water q...cations.,The Super-Q Plus water system features a ...
Medicine Products: